Author

M. J. West

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Assay:proteomics· 1

Frequent Co-Authors

A. Gunnell· 1 shared C. D. Wood· 1 shared C. S. Osborne· 1 shared E. Mancini· 1 shared O. O. Ojeniyi· 1 shared P. B. Correia· 1 shared P. J. Farrell· 1 shared R. Khatri· 1 shared

Activity by Year

2018-2018 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Gunnell

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Increased association between Epstein-Barr virus EBNA2 from type 2 strains and the transcriptional repressor BS69 restricts B cell growth

R. Ponnusamy, R. Khatri, P. B. Correia, E. Mancini, P. J. Farrell, M. J. West

This study identifies a third BS69 binding motif in type 2 EBNA2 that restricts B cell growth by enhancing EBNA2-BS69 interaction, explaining reduced transformation efficiency of type 2 EBV.

bioRxiv · Nov 7, 2018Microbiology

Enhancer control of miR-155 expression in Epstein-Barr virus infected B cells

C. D. Wood, T. Carvell, A. Gunnell, O. O. Ojeniyi, C. S. Osborne, M. J. West

This study identifies RBPJ-dependent enhancers that regulate miR-155 expression in EBV-infected B cells through EBNA2 and IRF4 activation.

bioRxiv · May 1, 2018Cancer Biology